New York, NY - (ACCESSWIRE) - 10/15/2013 - Equity Profile Report initiates its NASDAQ Active Stock Watch List adding Tesla Motors, Inc. (NASDAQ:TSLA), Ariad Pharmaceuticals Inc. (NASDAQ:ARIA), Coronado Biosciences, Inc. (NASDAQ:CNDO) and Amarin Corporation plc (NASDAQ:AMRN)
Tesla Motors, Inc. (NASDAQ:TSLA) a company that designs, develops, manufactures, and sells electric vehicles and electric vehicle powertrain components closed up in its previous session (+0.57%) on 7,694,299 shares traded after Tesla Unveiled Model X. Tesla Motors, Inc. (NASDAQ:TSLA) is currently up (+579.45%) from its recent 52-week low, which has prompted Equity Profile Report to add the stock to their NASDAQ Active Stock Watch List and Investor Poll.
To find out what other Investors are saying about Tesla Motors, Inc. (NASDAQ:TSLA)
Click Here: http://www.equityprofilereport.com/Survey.aspx?stock=TSLA&SubId=AW
Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) an oncology company that focuses on the discovery, development, and commercialization of medicines for cancer patients closed down in its previous session (-1.41%) on 34,036,203 shares traded after Ariad Pharmaceuticals was downgraded by Argus. Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) is currently down (-84.33%) from its recent 52-week high, which has prompted Equity Profile Report to add the stock to their NASDAQ Active Stock Watch List and Investor Poll.
To find out what other Investors are saying about Ariad Pharmaceuticals Inc. (NASDAQ:ARIA)
Click Here: http://www.equityprofilereport.com/Survey.aspx?stock=ARIA&SubId=AW
Coronado Biosciences, Inc. (NASDAQ:CNDO) a clinical stage biopharmaceutical company that focuses on the development of immunotherapy biologic agents for the treatment of autoimmune diseases and cancer closed down in its previous session (-66.90%) on 26,243,419 shares traded after Coronado Biosciences Announced Top-Line Results From Its TRUST-I Phase 2 Clinical Trial of TSO for the Treatment of Crohn's Disease. Coronado Biosciences, Inc. (NASDAQ:CNDO) is currently down (-86.38%) from its recent 52-week high, which has prompted Equity Profile Report to add the stock to their NASDAQ Active Stock Watch List and Investor Poll.
To find out what other Investors are saying about Coronado Biosciences, Inc. (NASDAQ:CNDO)
Click Here: http://www.equityprofilereport.com/Survey.aspx?stock=CNDO&SubId=AW
Amarin Corporation plc (NASDAQ:AMRN) a biopharmaceutical company that focuses on the development and commercialization therapeutic products for the treatment for cardiovascular diseases closed down in its previous session (-1.57%) on 16,889,145 shares traded after The Law Firm of Levi & Korsinsky, LLP Launched an Investigation into Claims on Behalf of Shareholders of Amarin Corporation. Amarin Corporation plc (NASDAQ:AMRN) is currently down (-65.28%) from its recent 52-week high, which has prompted Equity Profile Report to add the stock to their NASDAQ Active Stock Watch List and Investor Poll.
To find out what other Investors are saying about Amarin Corporation plc (NASDAQ:AMRN)
Click Here: http://www.equityprofilereport.com/Survey.aspx?stock=AMRN&SubId=AW
Equityprofilereport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities. Through a vast network of IR professionals Equityprofilereport.com is often aware of several large investor awareness campaigns being deployed. Timing is important when trading Small Caps and Penny Stocks.
Simply sign up for free and start receiving exclusive alerts.
Subscribe Here:
http://www.equityprofilereport.com/ Disclosure: Equityprofilereport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit Equityprofilereport.com website, for complete risks and disclosures.
Contact Info:
Equity Profile Report
editor@Equityprofilereport.com